Currently, Prostate-Specific Antigen (PSA) is commonly used as a diagnostic marker for PCa assessment, together with digital rectal examinations (DRE) and Magnetic Resonance Imaging (MRI). This evidence concerns the gene KLK3 and posterior cortical atrophy.